文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

β1肾上腺素能受体通过调节调节性T细胞抑制功能参与脓毒症诱导的免疫抑制

The β 1 -Adrenergic Receptor Contributes to Sepsis-Induced Immunosuppression Through Modulation of Regulatory T-Cell Inhibitory Function.
PubMed 文献 · Crit Care Med · 2022-02-18
一句话结论小鼠脓毒症模型中,β1肾上腺素能受体阻断可逆转CD4 T细胞减少和调节性T细胞比例升高,并改善心血管效率。

该实验研究在C57BL/6小鼠行盲肠结扎穿孔诱导重度脓毒症,分别给予选择性β1肾上腺素能受体阻断剂艾司洛尔或使用β1肾上腺素能受体敲除小鼠。术后18小时,野生型脓毒症小鼠出现脾CD4 T细胞减少、CD4 T细胞增殖下降和调节性T细胞比例升高;药物和遗传性β1肾上腺素能受体阻断均逆转上述改变,并维持CD4 T细胞增殖能力。阻断组促炎和抗炎介质整体下降,心脏功率指数维持而心率如预期下降,心血管效率改善。作者认为β1肾上腺素能受体激活增强调节性T细胞抑制功能,参与脓毒症免疫抑制,阻断该受体可能具有免疫调节作用。

要点

  • 野生型盲肠结扎穿孔小鼠术后18小时出现脾CD4 T细胞减少、CD4 T细胞增殖下降、调节性T细胞比例升高三项免疫抑制替代指标。
  • 药物(艾司洛尔)和遗传性β1肾上腺素能受体阻断均逆转脓毒症对CD4 T细胞和调节性T细胞比例的影响,并维持CD4 T细胞增殖能力。
  • β1肾上腺素能受体阻断的盲肠结扎穿孔小鼠促炎和抗炎介质整体下降,心脏功率指数维持、心血管效率改善,心率如预期下降。
  • 作者认为β1肾上腺素能受体激活增强调节性T细胞抑制功能,从而参与脓毒症诱导的免疫抑制。
  • 作者认为β1肾上腺素能受体阻断可减弱上述免疫抑制,提示该治疗在脓毒症管理中可能具有免疫调节作用。

适用人群与场景

  • C57BL/6小鼠,行盲肠结扎穿孔诱导重度脓毒症,包括野生型(β1+/+)和β1肾上腺素能受体敲除(β1-/-)小鼠。

处置流程与药物剂量

  • 野生型盲肠结扎穿孔小鼠给予艾司洛尔(选择性β1肾上腺素能受体阻断剂),或使用β1肾上腺素能受体敲除小鼠,术后18小时行超声心动图并采集血液和脾脏分析淋巴细胞功能。

研究设计与关键结果

  • 术后18小时,β1+/+盲肠结扎穿孔小鼠表现出重度脓毒症特征和三项免疫抑制替代指标:脾CD4 T细胞减少、CD4 T细胞增殖下降、调节性T淋巴细胞比例升高。
  • 药物和遗传性β1肾上腺素能受体阻断逆转了脓毒症对CD4 T细胞和调节性T淋巴细胞比例的影响,并维持CD4 T细胞增殖能力。
  • β1肾上腺素能受体阻断的盲肠结扎穿孔小鼠促炎和抗炎介质整体下降,体内心血管效率改善,心脏功率指数维持,尽管心率如预期下降。

证据类型、等级与局限

  • 证据类型:实验研究(小鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为β1肾上腺素能受体激活增强调节性T淋巴细胞抑制功能,从而参与脓毒症诱导的免疫抑制。
  • 作者认为β1肾上腺素能受体阻断可减弱上述免疫抑制,提示该治疗在脓毒症管理中可能具有免疫调节作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Although cardiovascular benefits of β 1 -adrenergic receptor blockade have been described in sepsis, little is known about its impact on the adaptive immune response, specifically CD4 T cells. Herein, we study the effects of β 1 -adrenergic receptor modulation on CD4 T-cell function in a murine model of sepsis.

DESIGN: Experimental study.

SETTING: University laboratory.

SUBJECTS: C57BL/6 mice.

INTERVENTIONS: High-grade sepsis was induced by cecal ligation and puncture in wild-type mice (β 1+/+ ) with or without esmolol (a selective β 1 -adrenergic receptor blocker) or in β 1 -adrenergic receptor knockout mice (β 1-/- ). At 18 hours after surgery, echocardiography was performed with blood and spleen collected to analyze lymphocyte function.

MEASUREMENTS AND MAIN RESULTS: At 18 hours, β 1+/+ cecal ligation and puncture mice exhibited characteristics of high-grade sepsis and three surrogate markers of immunosuppression, namely decreased splenic CD4 T cells, reduced CD4 T-cell proliferation, and increased regulatory T lymphocyte cell proportions. Pharmacologic and genetic β 1 -adrenergic receptor blockade reversed the impact of sepsis on CD4 T and regulatory T lymphocyte proportions and maintained CD4 T-cell proliferative capacity. β 1 -adrenergic receptor blocked cecal ligation and puncture mice also exhibited a global decrease in both pro- and anti-inflammatory mediators and improved in vivo cardiovascular efficiency with maintained cardiac power index despite the expected decrease in heart rate.

CONCLUSIONS: β 1 -adrenergic receptor activation enhances regulatory T lymphocyte inhibitory function and thus contributes to sepsis-induced immunosuppression. This can be attenuated by β 1 -adrenergic receptor blockade, suggesting a potential immunoregulatory role for this therapy in the management of sepsis.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Durand M, Hagimont E, Louis H, et al. The β 1 -Adrenergic Receptor Contributes to Sepsis-Induced Immunosuppression Through Modulation of Regulatory T-Cell Inhibitory Function. Crit Care Med. 2022. PMID: 35234431. doi:10.1097/CCM.0000000000005503

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。